▶ 調査レポート

ナノメディシンの世界市場:市場規模・現状・予測

• 英文タイトル:Global Nanomedicine Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。ナノメディシンの世界市場:市場規模・現状・予測 / Global Nanomedicine Market Size, Status and Forecast 2019-2025 / QYR9ST04963資料のイメージです。• レポートコード:QYR9ST04963
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、ナノメディシンの世界市場について調査・分析し、ナノメディシンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス)、用途別(セグメンテーション包含腫瘍学、感染症、循環器、整形外科、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のナノメディシン市場動向
・主要企業別マーケットシェア
・ナノメディシンの種類別市場規模2014-2019
(量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス)
・ナノメディシンの用途別市場規模2014-2019
(セグメンテーション包含腫瘍学、感染症、循環器、整形外科、その他)
・ナノメディシンの北米市場:主要企業・種類別/用途別市場規模
・ナノメディシンのヨーロッパ市場:主要企業・種類別/用途別市場規模
・ナノメディシンの中国市場:主要企業・種類別/用途別市場規模
・ナノメディシンの日本国内市場:主要企業・種類別/用途別市場規模
・ナノメディシンの東南アジア市場:主要企業・種類別/用途別市場規模
・ナノメディシンのインド市場:主要企業・種類別/用途別市場規模
・ナノメディシンの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Combimatrix、Ablynx、Abraxis Bioscience、Celgene、Mallinckrodt、Arrowhead Research、GE Healthcare、Merck、Pfizer、Nanosphere、Epeius Biotechnologies、Cytimmune Sciences、Nanospectra Biosciences)
・ナノメディシンの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.
Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.
In 2018, the global Nanomedicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nanomedicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicine development in United States, Europe and China.

The key players covered in this study
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences

Market segment by Type, the product can be split into
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Market segment by Application, split into
Segmentation encompasses oncology
Infectious diseases
Cardiology
Orthopedics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nanomedicine status, future forecast, growth opportunity, key market and key players.
To present the Nanomedicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nanomedicine Market Size Growth Rate by Type (2014-2025)
1.4.2 Quantum dots
1.4.3 Nanoparticles
1.4.4 Nanoshells
1.4.5 Nanotubes
1.4.6 Nanodevices
1.5 Market by Application
1.5.1 Global Nanomedicine Market Share by Application (2014-2025)
1.5.2 Segmentation encompasses oncology
1.5.3 Infectious diseases
1.5.4 Cardiology
1.5.5 Orthopedics
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nanomedicine Market Size
2.2 Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions (2014-2025)
2.2.2 Nanomedicine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nanomedicine Market Size by Manufacturers
3.1.1 Global Nanomedicine Revenue by Manufacturers (2014-2019)
3.1.2 Global Nanomedicine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.2 Nanomedicine Key Players Head office and Area Served
3.3 Key Players Nanomedicine Product/Solution/Service
3.4 Date of Enter into Nanomedicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nanomedicine Market Size by Type (2014-2019)
4.2 Global Nanomedicine Market Size by Application (2014-2019)

5 United States
5.1 United States Nanomedicine Market Size (2014-2019)
5.2 Nanomedicine Key Players in United States
5.3 United States Nanomedicine Market Size by Type
5.4 United States Nanomedicine Market Size by Application

6 Europe
6.1 Europe Nanomedicine Market Size (2014-2019)
6.2 Nanomedicine Key Players in Europe
6.3 Europe Nanomedicine Market Size by Type
6.4 Europe Nanomedicine Market Size by Application

7 China
7.1 China Nanomedicine Market Size (2014-2019)
7.2 Nanomedicine Key Players in China
7.3 China Nanomedicine Market Size by Type
7.4 China Nanomedicine Market Size by Application

8 Japan
8.1 Japan Nanomedicine Market Size (2014-2019)
8.2 Nanomedicine Key Players in Japan
8.3 Japan Nanomedicine Market Size by Type
8.4 Japan Nanomedicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nanomedicine Market Size (2014-2019)
9.2 Nanomedicine Key Players in Southeast Asia
9.3 Southeast Asia Nanomedicine Market Size by Type
9.4 Southeast Asia Nanomedicine Market Size by Application

10 India
10.1 India Nanomedicine Market Size (2014-2019)
10.2 Nanomedicine Key Players in India
10.3 India Nanomedicine Market Size by Type
10.4 India Nanomedicine Market Size by Application

11 Central & South America
11.1 Central & South America Nanomedicine Market Size (2014-2019)
11.2 Nanomedicine Key Players in Central & South America
11.3 Central & South America Nanomedicine Market Size by Type
11.4 Central & South America Nanomedicine Market Size by Application

12 International Players Profiles
12.1 Combimatrix
12.1.1 Combimatrix Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nanomedicine Introduction
12.1.4 Combimatrix Revenue in Nanomedicine Business (2014-2019)
12.1.5 Combimatrix Recent Development
12.2 Ablynx
12.2.1 Ablynx Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nanomedicine Introduction
12.2.4 Ablynx Revenue in Nanomedicine Business (2014-2019)
12.2.5 Ablynx Recent Development
12.3 Abraxis Bioscience
12.3.1 Abraxis Bioscience Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nanomedicine Introduction
12.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2014-2019)
12.3.5 Abraxis Bioscience Recent Development
12.4 Celgene
12.4.1 Celgene Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nanomedicine Introduction
12.4.4 Celgene Revenue in Nanomedicine Business (2014-2019)
12.4.5 Celgene Recent Development
12.5 Mallinckrodt
12.5.1 Mallinckrodt Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nanomedicine Introduction
12.5.4 Mallinckrodt Revenue in Nanomedicine Business (2014-2019)
12.5.5 Mallinckrodt Recent Development
12.6 Arrowhead Research
12.6.1 Arrowhead Research Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nanomedicine Introduction
12.6.4 Arrowhead Research Revenue in Nanomedicine Business (2014-2019)
12.6.5 Arrowhead Research Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nanomedicine Introduction
12.7.4 GE Healthcare Revenue in Nanomedicine Business (2014-2019)
12.7.5 GE Healthcare Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nanomedicine Introduction
12.8.4 Merck Revenue in Nanomedicine Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nanomedicine Introduction
12.9.4 Pfizer Revenue in Nanomedicine Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Nanosphere
12.10.1 Nanosphere Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nanomedicine Introduction
12.10.4 Nanosphere Revenue in Nanomedicine Business (2014-2019)
12.10.5 Nanosphere Recent Development
12.11 Epeius Biotechnologies
12.12 Cytimmune Sciences
12.13 Nanospectra Biosciences

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Nanomedicine Key Market Segments
Table Key Players Nanomedicine Covered
Table Global Nanomedicine Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nanomedicine Market Size Market Share by Type 2014-2025
Figure Quantum dots Figures
Table Key Players of Quantum dots
Figure Nanoparticles Figures
Table Key Players of Nanoparticles
Figure Nanoshells Figures
Table Key Players of Nanoshells
Figure Nanotubes Figures
Table Key Players of Nanotubes
Figure Nanodevices Figures
Table Key Players of Nanodevices
Table Global Nanomedicine Market Size Growth by Application 2014-2025 (Million US$)
Figure Segmentation encompasses oncology Case Studies
Figure Infectious diseases Case Studies
Figure Cardiology Case Studies
Figure Orthopedics Case Studies
Figure Others Case Studies
Figure Nanomedicine Report Years Considered
Table Global Nanomedicine Market Size 2014-2025 (Million US$)
Figure Global Nanomedicine Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nanomedicine Market Size by Regions 2014-2025 (Million US$)
Table Global Nanomedicine Market Size by Regions 2014-2019 (Million US$)
Table Global Nanomedicine Market Share by Regions 2014-2019
Figure Global Nanomedicine Market Share by Regions 2014-2019
Figure Global Nanomedicine Market Share by Regions 2019
Table Market Top Trends
Table Global Nanomedicine Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nanomedicine Market Share by Manufacturers (2014-2019)
Figure Global Nanomedicine Market Share by Manufacturers in 2018
Table Global Nanomedicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nanomedicine Product/Solution/Service
Table Date of Enter into Nanomedicine Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table Global Nanomedicine Market Size Share by Type (2014-2019)
Figure Global Nanomedicine Market Size Market Share by Type (2014-2019)
Table Global Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table Global Nanomedicine Market Size Share by Application (2014-2019)
Figure Global Nanomedicine Market Size Market Share by Application (2014-2019)
Figure Global Nanomedicine Revenue Market Share by Application in 2018
Figure United States Nanomedicine Market Size 2014-2019 (Million US$)
Table United States Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table United States Key Players Nanomedicine Market Share (2018-2019)
Table United States Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table United States Nanomedicine Market Share by Type (2014-2019)
Table United States Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table United States Nanomedicine Market Share by Application (2014-2019)
Figure Europe Nanomedicine Market Size 2014-2019 (Million US$)
Table Europe Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table Europe Key Players Nanomedicine Market Share (2018-2019)
Table Europe Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table Europe Nanomedicine Market Share by Type (2014-2019)
Table Europe Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table Europe Nanomedicine Market Share by Application (2014-2019)
Figure China Nanomedicine Market Size 2014-2019 (Million US$)
Table China Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table China Key Players Nanomedicine Market Share (2018-2019)
Table China Nanomedicine Market Size by Type (2014-20189) (Million US$)
Table China Nanomedicine Market Share by Type (2014-2019)
Table China Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table China Nanomedicine Market Share by Application (2014-2019)
Figure Japan Nanomedicine Market Size 2014-2019 (Million US$)
Table Japan Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table Japan Key Players Nanomedicine Market Share (2018-2019)
Table Japan Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table Japan Nanomedicine Market Share by Type (2014-2019)
Table Japan Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table Japan Nanomedicine Market Share by Application (2014-2019)
Figure Southeast Asia Nanomedicine Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nanomedicine Market Share (2018-2019)
Table Southeast Asia Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nanomedicine Market Share by Type (2014-2019)
Table Southeast Asia Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nanomedicine Market Share by Application (2014-2019)
Figure India Nanomedicine Market Size 2014-2019 (Million US$)
Table India Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table India Key Players Nanomedicine Market Share (2018-2019)
Table India Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table India Nanomedicine Market Share by Type (2014-2019)
Table India Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table India Nanomedicine Market Share by Application (2014-2019)
Figure Central & South America Nanomedicine Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nanomedicine Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nanomedicine Market Share (2018-2019)
Table Central & South America Nanomedicine Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nanomedicine Market Share by Type (2014-2019)
Table Central & South America Nanomedicine Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nanomedicine Market Share by Application (2014-2019)
Table Combimatrix Company Details
Table Combimatrix Revenue in Nanomedicine Business (2014-2019) (Million US$)
Figure Combimatrix Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Combimatrix Recent Development
Table Ablynx Company Details
Table Ablynx Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Ablynx Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Ablynx Recent Development
Table Abraxis Bioscience Company Details
Table Abraxis Bioscience Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Abraxis Bioscience Recent Development
Table Celgene Company Details
Table Celgene Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Celgene Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Mallinckrodt Recent Development
Table Arrowhead Research Company Details
Table Arrowhead Research Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Arrowhead Research Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table GE Healthcare Recent Development
Table Merck Company Details
Table Merck Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Pfizer Recent Development
Table Nanosphere Company Details
Table Nanosphere Revenue in Nanomedicine Business (2014-2019)(Million US$)
Figure Nanosphere Revenue Growth Rate in Nanomedicine Business (2014-2019)
Table Nanosphere Recent Development
Table Epeius Biotechnologies Company Details
Table Cytimmune Sciences Company Details
Table Nanospectra Biosciences Company Details
Table Global Nanomedicine Market Size by Regions (Million US$) 2019-2025
Figure Global Nanomedicine Market Size Share by Regions (2019-2025)
Figure Global Nanomedicine Market Size Share by Regions in 2025
Figure United States Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure China Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure India Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nanomedicine Market Size Forecast (2019-2025)(Million USD)
Table Global Nanomedicine Market Size by Product (2019-2025) (Million US$)
Figure Global Nanomedicine Market Size by Product (2019-2025)
Figure Global Nanomedicine Market Size by Product in 2025
Table Global Nanomedicine Market Size by Application (2019-2025) (Million US$)
Figure Global Nanomedicine Market Size by Application (2019-2025)
Figure Global Nanomedicine Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources